https://pharmatlas.org/ 2026-04-06T07:38:35+00:00 https://pharmatlas.org/ https://pharmatlas.org/lib/exe/fetch.php?media=logo.png text/html 2026-02-13T00:41:13+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:sulfonylureas:glimepiride&rev=1770943273&do=diff Glimepiride Glimepiride is a second-generation sulfonylurea that stimulates pancreatic insulin secretion. It is commonly used due to once-daily dosing and a lower risk of prolonged hypoglycemia compared to glyburide. → Sulfonylureas ---------- Mechanism of Action text/html 2026-02-13T00:40:17+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:sulfonylureas:glipizide&rev=1770943217&do=diff Glipizide Glipizide is a second-generation sulfonylurea that stimulates pancreatic insulin secretion. It is one of the most commonly used sulfonylureas. → Sulfonylureas ---------- Mechanism of Action Glipizide binds to: * Sulfonylurea receptor (SUR1) * text/html 2026-02-13T00:40:46+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:sulfonylureas:glyburide&rev=1770943246&do=diff Glyburide Glyburide is a second-generation sulfonylurea that stimulates pancreatic insulin secretion. It is associated with a higher risk of prolonged hypoglycemia compared to other sulfonylureas. → Sulfonylureas ---------- Mechanism of Action Glyburide binds to: text/html 2026-02-13T00:39:39+00:00 Anonymous (anonymous@undisclosed.example.com) https://pharmatlas.org/doku.php?id=endocrine:sulfonylureas:start&rev=1770943179&do=diff Sulfonylureas Sulfonylureas are insulin secretagogues that stimulate pancreatic beta cells to release insulin. They lower blood glucose by increasing endogenous insulin secretion. They carry a significant risk of hypoglycemia. → Diabetes Pharmacology ---------- Mechanism of Action